How long to onset of antidepressant action: a meta‐analysis of patients treated with fluoxetine or placebo

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International Clinical Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004850-199400940-00003PMID 7868846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluoxetine and desipramine in major depressive disorder.

  1993cited by this paper
• Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine

  1993cited by this paper
• Neuroendocrine markers of serotonin responsivity in depression.

  1992cited by this paper
• Speed of onset of action of the newer antidepressants--fluoxetine and bupropion.

  1991cited by this paper
• Onset of response in relation to outcome in depressed outpatients with placebo and imipramine.

  1989cited by this paper
• Speed of onset of action of the newer antidepressants.

  1984cited by this paper
• Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

  1981cited by this paper
• A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.

  1975cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• The role of serotonin in depression—A historical roundup and future directions

  2024cites this paper
• Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action

  2021cites this paper
• Ketamine normalizes subgenual cingulate cortex hyper-activity in depression

  2020cites this paper
• Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder

  2018cites this paper
• Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

  2017cites this paper
• Novel implications of lost serotonin transporter function on platelet biology

  2016cites this paper
• Long-term Ameliorative Effects of the Antidepressant Fluoxetine Exposure on Cognitive Deficits in 3 × TgAD Mice

  2016cites this paper
• Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.

  2015cites this paper
• Developments in the field of antidepressants, where do we go now?

  2015cites this paper
• Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients

  2014cites this paper
• Novel therapeutic strategies in major depression: focus on RNAi and ketamine.

  2014cites this paper
• Future directions for serotonin and antidepressants.

  2013cites this paper
• Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study

  2013cites this paper
• Should We Treat Depression with drugs or psychological interventions? A Reply to Ioannidis

  2011cites this paper
• Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI

  2011cites this paper
• Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel.

  2011cites this paper
• A reproductive subtype of depression: conceptualizing models and moving toward etiology.

  2009cites this paper
• How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

  2009cites this paper
• Rapid Onset of Antidepressant Action: A New Paradigm in the Research and Treatment of Major Depression

  2009cites this paper
• The Impact of Efficacious Treatments for Major Depressive Disorder on Remission Rates of Specific Symptoms: A Re-Analysis of the Treatment of Depression Collaborative Research Program

  2009cites this paper
• Timing of Clinical Improvement and Symptom Resolution in the Treatment of Major Depressive Disorder

  2008cites this paper
• Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

  2008cites this paper
• Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.

  2007cites this paper
• Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

  2006cites this paper
• Pindolol augmentation of antidepressant response.

  2006cites this paper
• Chapter 6.3 The use of brain microdialysis in antidepressant drug research

  2006cites this paper
• Is there a delay in the antidepressant effect? A meta-analysis.

  2005cites this paper
• The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients

  2005cites this paper
• What should animal models of depression model?

  2005cites this paper
• Akzeleration der Antidepressivaresponse und Augmentation mit Pindolol

  2005cites this paper
• Symptom clusters as predictors of late response to antidepressant treatment.

  2005cites this paper
• Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder

  2004cites this paper
• Time Course of Response to Antidepressants in Late-Life Major Depression

  2004cites this paper
• Annals of General Hospital Psychiatry Open Access Fluoxetine: a Review on Evidence Based Medicine

  2004cites this paper
• Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression

  2004cites this paper
• [Definitions and recommendations for studying the delay of antidepressant action. Part 3: methodological aspects].

  2003cites this paper
• Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study

  2003cites this paper
• Animal models of depression: are there any?

  2003cites this paper
• Fluoxetine versus placebo in posttraumatic stress disorder.

  2002cites this paper
• Serotonin-selektive Antidepressiva(SSRI, DSA)

  2002cites this paper
• Selecting methodologies for the evaluation of differences in time to response between antidepressants.

  2002cites this paper
• Strategies for the rapid treatment of depression

  2001cites this paper
• Mechanisms underlying the speed of onset of antidepressant response

  2001cites this paper
• Cost‐effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double‐blind clinical trial

  2000cites this paper
• Side effects and time course of response in a placebo-controlled trial of fluoxetine for the treatment of geriatric depression.

  2000cites this paper
• Early termination of antidepressant drug treatment.

  2000cites this paper
• Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.

  1999cites this paper
• Criteria for early onset of action of an antidepressant from the clinical trial logistics point of view – methodological considerations

  1999cites this paper
• A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

  1999cites this paper
• A double-blind, randomized, placebo-controlled trial of Pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors

  1999cites this paper
• Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression

  1999cites this paper
• Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.

  1999cites this paper
• Displacement of the binding of 5‐HT1A receptor ligands to pre‐ and postsynaptic receptors by (‐)pindolol. A comparative study in rodent, primate and human brain

  1999cites this paper
• A Risk-Benefit Assessment of Pharmacotherapies for Clinical Depression in Children and Adolescents

  1999cites this paper
• Comienzo de la mejoría con fluoxetina y moclobemida

  1998cites this paper
• Fundamentals of financial statement analysis for academic physician managers

  1998cites this paper
• Need for a New Paradigm for the Clinical Trials of Antidepressants

  1998influential citation
• A double‐blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients

  1998cites this paper
• Pharmacologic treatment for children and adolescents with anxiety disorders.

  1998cites this paper
• The speech analysis approach to determining onset of improvement under antidepressants.

  1998cites this paper
• Rapid response to psychosocial treatment for adolescent depression: a two-year follow-up.

  1998cites this paper
• Onset of improvement under fluoxetine and moclobemide

  1998cites this paper
• Delayed Onset of Action of Antidepressants

  1998cites this paper
• Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.

  1997cites this paper
• Fast‐onset antidepressants

  1997cites this paper
• Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression.

  1997cites this paper
• Pharmacology of antidepressants.

  1997cites this paper
• Antidepressants.

  1997cites this paper
• Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?

  1997cites this paper
• Is There an Advantage to Venlafaxine in Comparison with Other Antidepressants?

  1997cites this paper
• Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors

  1997cites this paper
• Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

  1997cites this paper
• Onset of action under antidepressant treatment

  1997cites this paper
• On Lightening Up: Improvement Trajectories in Recovery from Depression

  1996cites this paper
• Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses.

  1996cites this paper
• Delayed Onset of Action of Antidepressant Drugs? Survey of Results of Zurich Meta-Analyses

  1996cites this paper
• Prospects for the Development of New Treatments with a Rapid Onset of Action in Affective Disorders

  1996cites this paper
• Are 2-week trials sufficient to indicate efficacy?

  1995cites this paper
• Current awareness in human psychopharmacology

  1995cites this paper